Table 4.
Statistical analyses of variables in patients with Pneumocystis pneumonia, according to the underlying condition.
| Underlying condition | HM (n = 11) | SOT (n = 16) | SAIID (n = 9) | p # |
|---|---|---|---|---|
| Median age, years (range; IQR) | 58 (26–78; 11) | 65 (33–77; 10.5) | 65 (51–78; 12.5) | 0.059 |
| Male gender, n (%) | 7 (63.6) | 10 (62.5) | 6 (66.7) | 0.39 |
| Serum BG level, pg/ml, median (range; IQR) | 211 (31–2,771; 1,489) | 3,473 (1170–5,000; 2013) | 3,480 (610–5,000; 2,515) | <10–4#,$ |
| PCR Ct value in BALF samples, mean ± SD (range) | 27.09 ± 3.59 (19–34) | 20.87 ± 3.42 (15–26.5) | 23.17 ± 4.14 (19.5–30) | 0.0006#,$ |
BALF, bronchoalveolar lavage fluid; BG, (1,3)-β-D-glucan; Ct, cycle threshold; HM, hematological malignancy; IQR, interquartile range; PCP, Pneumocystis pneumonia; SD, standard deviation; SAIID, systemic autoimmune or inflammatory disorder; SOT, solid organ transplant.
#
3-group comparison by Kruskal-Wallis test.
$
Statistically significant; pairwise comparison by Bonferroni’s test was subsequently performed.